{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T18:05:52Z","timestamp":1790186752728,"version":"4.1.0"},"reference-count":42,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,6,1]],"date-time":"2020-06-01T00:00:00Z","timestamp":1590969600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,6,1]],"date-time":"2020-06-01T00:00:00Z","timestamp":1590969600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,6,1]],"date-time":"2020-06-01T00:00:00Z","timestamp":1590969600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2020,6,1]],"date-time":"2020-06-01T00:00:00Z","timestamp":1590969600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2020,6,1]],"date-time":"2020-06-01T00:00:00Z","timestamp":1590969600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2020,6,1]],"date-time":"2020-06-01T00:00:00Z","timestamp":1590969600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2020,6,1]],"date-time":"2020-06-01T00:00:00Z","timestamp":1590969600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100018957","name":"Cara","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100018957","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000839","name":"University of Reading","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000839","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Controlled Release"],"published-print":{"date-parts":[[2020,6]]},"DOI":"10.1016\/j.jconrel.2020.02.037","type":"journal-article","created":{"date-parts":[[2020,2,26]],"date-time":"2020-02-26T11:36:47Z","timestamp":1582717007000},"page":"227-235","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"special_numbering":"C","title":["Conjugation of haloperidol to PEG allows peripheral localisation of haloperidol and eliminates CNS extrapyramidal effects"],"prefix":"10.1016","volume":"322","author":[{"given":"Az Alddien","family":"Natfji","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dmitry O.","family":"Nikitin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Irina I.","family":"Semina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rouslan I.","family":"Moustafine","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vitaliy V.","family":"Khutoryanskiy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hong","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gary J.","family":"Stephens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kimberly A.","family":"Watson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helen M.I.","family":"Osborn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesca","family":"Greco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jconrel.2020.02.037_bb0005","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/j.ejpb.2014.03.012","article-title":"Blood\u2013brain barrier models and their relevance for a successful development of CNS drug delivery systems: a review","volume":"87","author":"Bicker","year":"2014","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.jconrel.2020.02.037_bb0010","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1080\/23808993.2018.1424535","article-title":"Drug repositioning: current approaches and their implications in the precision medicine era","volume":"3","author":"Talevi","year":"2018","journal-title":"Expert Rev. Precis. Med. Drug Dev."},{"key":"10.1016\/j.jconrel.2020.02.037_bb0015","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1007\/s40263-016-0405-9","article-title":"Crossing the blood\u2013brain barrier: recent advances in drug delivery to the brain","volume":"31","author":"Patel","year":"2017","journal-title":"CNS Drugs."},{"key":"10.1016\/j.jconrel.2020.02.037_bb0020","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.ejphar.2015.08.016","article-title":"Why are second-generation H1-antihistamines minimally sedating?","volume":"765","author":"Hu","year":"2015","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.jconrel.2020.02.037_bb0025","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.cocis.2017.07.004","article-title":"Feasibility of polymer-drug conjugates for non-cancer applications","volume":"31","author":"Natfji","year":"2017","journal-title":"Curr. Opin. Colloid Interface Sci."},{"key":"10.1016\/j.jconrel.2020.02.037_bb0030","doi-asserted-by":"crossref","first-page":"4690","DOI":"10.1039\/C6CS00076B","article-title":"Blood\u2013brain barrier shuttle peptides: an emerging paradigm for brain delivery","volume":"45","author":"Oller-Salvia","year":"2016","journal-title":"Chem. Soc. Rev."},{"key":"10.1016\/j.jconrel.2020.02.037_bb0035","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1038\/nm1002","article-title":"Targeting angiogenesis with a conjugate of HPMA copolymer and TNP-470","volume":"10","author":"Satchi-Fainaro","year":"2004","journal-title":"Nat. Med."},{"key":"10.1016\/j.jconrel.2020.02.037_bb0040","first-page":"1","article-title":"Clinical pharmacokinetics and pharmacodynamics of naloxegol, a peripherally acting \u03bc-opioid receptor antagonist","author":"Bui","year":"2016","journal-title":"Clin. Pharmacokinet."},{"key":"10.1016\/j.jconrel.2020.02.037_bb0045","doi-asserted-by":"crossref","first-page":"7204","DOI":"10.1039\/C6PY01418F","article-title":"A novel PEG-haloperidol conjugate with a non-degradable linker shows the feasibility of using polymer-drug conjugates in a non-prodrug fashion","volume":"7","author":"Heath","year":"2016","journal-title":"Polym. Chem."},{"key":"10.1016\/j.jconrel.2020.02.037_bb0050","first-page":"354","article-title":"A simple predictive model for blood-brain barrier penetration","volume":"60","author":"Fu","year":"2005","journal-title":"Pharmazie."},{"key":"10.1016\/j.jconrel.2020.02.037_bb0055","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1111\/j.1476-5381.2010.01010.x","article-title":"Analysis of the actions of the novel dopamine receptor-directed compounds (S)-OSU6162 and ACR16 at the D(2) dopamine receptor","volume":"161","author":"Kara","year":"2010","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.jconrel.2020.02.037_bb0060","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/S0021-9258(19)52451-6","article-title":"Protein measurement with the folin phenol reagent","volume":"193","author":"Lowry","year":"1951","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.jconrel.2020.02.037_bb0065","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1021\/jm020406h","article-title":"Surflex: fully automatic flexible molecular docking using a molecular similarity-based search engine","volume":"46","author":"Jain","year":"2003","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.jconrel.2020.02.037_bb0070","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1038\/nature25758","article-title":"Structure of the D2 dopamine receptor bound to the atypical antipsychotic drug risperidone","volume":"555","author":"Wang","year":"2018","journal-title":"Nature."},{"key":"10.1016\/j.jconrel.2020.02.037_bb0075","series-title":"Maestro","author":"Schrodinger","year":"2019"},{"key":"10.1016\/j.jconrel.2020.02.037_bb0080","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1002\/bmb.2006.494034062672","article-title":"EZ-Viz, a tool for simplifying molecular viewing in PyMOL","volume":"34","author":"Grell","year":"2006","journal-title":"Biochem. Mol. Biol. Educ."},{"issue":"8","key":"10.1016\/j.jconrel.2020.02.037_bb0085","article-title":"The PyMOL molecular graphics system","volume":"1","author":"Schrodinger","year":"2015","journal-title":"Version"},{"key":"10.1016\/j.jconrel.2020.02.037_bb0090","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.ejpb.2014.02.007","article-title":"Haloperidol-loaded intranasally administered lectin functionalized poly(ethylene glycol)\u2013block-poly(d,l)-lactic-co-glycolic acid (PEG\u2013PLGA) nanoparticles for the treatment of schizophrenia","volume":"87","author":"Piazza","year":"2020","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.jconrel.2020.02.037_bb0095","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1124\/mol.115.100172","article-title":"In vitro and in vivo identification of novel positive allosteric modulators of the human dopamine D2 and D3 receptor","volume":"89","author":"Wood","year":"2016","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.jconrel.2020.02.037_bb0100","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1139\/y82-036","article-title":"The Schild regression in the process of receptor classification","volume":"60","author":"Kenakin","year":"1982","journal-title":"Can. J. Physiol. Pharmacol."},{"key":"10.1016\/j.jconrel.2020.02.037_bb0105","doi-asserted-by":"crossref","first-page":"435","DOI":"10.2165\/00003088-199937060-00001","article-title":"Pharmacokinetics of haloperidol","volume":"37","author":"Kudo","year":"1999","journal-title":"Clin. Pharmacokinet."},{"key":"10.1016\/j.jconrel.2020.02.037_bb0110","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1111\/j.1365-2125.1981.tb01135.x","article-title":"Total and free serum haloperidol levels in schizophrenic patients and the effect of age thioridazine and fatty acid on haloperidol-serum protein binding in vitro","volume":"11","author":"Rowell","year":"1981","journal-title":"Br. J. Clin. Pharmacol."},{"key":"10.1016\/j.jconrel.2020.02.037_bb0115","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1055\/s-2007-979322","article-title":"Therapeutic window of serum haloperidol concentration in acute schizophrenia and schizoaffective disorder","volume":"31","author":"Ulrich","year":"1998","journal-title":"Pharmacopsychiatry."},{"key":"10.1016\/j.jconrel.2020.02.037_bb0120","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.0400100101","article-title":"The predicted 3D structure of the human D2 dopamine receptor and the binding site and binding affinities for agonists and antagonists","volume":"101","author":"Kalani","year":"2004","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.jconrel.2020.02.037_bb0125","doi-asserted-by":"crossref","first-page":"1970","DOI":"10.1021\/ci1002747","article-title":"Subtype selectivity of dopamine receptor ligands: insights from structure and ligand-based methods","volume":"50","author":"Wang","year":"2010","journal-title":"J. Chem. Inf. Model."},{"key":"10.1016\/j.jconrel.2020.02.037_bb0130","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.1021\/cn300142q","article-title":"Comparison of the binding and functional properties of two structurally different D2 dopamine receptor subtype selective compounds","volume":"3","author":"Luedtke","year":"2012","journal-title":"ACS Chem. Neurosci."},{"key":"10.1016\/j.jconrel.2020.02.037_bb0135","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1021\/acs.jcim.5b00457","article-title":"Ligand binding pathways of clozapine and haloperidol in the dopamine D2 and D3 receptors","volume":"56","author":"Thomas","year":"2016","journal-title":"J. Chem. Inf. Model."},{"key":"10.1016\/j.jconrel.2020.02.037_bb0140","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1146\/annurev.pharmtox.42.091101.144224","article-title":"The binding site of aminergic G protein\u2013coupled receptors: the transmembrane segments and second extracellular loop","volume":"42","author":"Shi","year":"2002","journal-title":"Annu. Rev. Pharmacol. Toxicol."},{"key":"10.1016\/j.jconrel.2020.02.037_bb0145","doi-asserted-by":"crossref","DOI":"10.1016\/S0022-3565(24)39293-6","article-title":"A Highly Conserved Aspartic Acid (Asp-155) Anchors the Terminal Amine Moiety of Tryptamines and Is Involved in Membrane Targeting of the 5-HT<sub>2A<\/sub> Serotonin Receptor But Does Not Participate in Activation via a \u201cSalt-Bridge Disruption,\u201d","volume":"293","author":"Kristiansen","year":"2000","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.jconrel.2020.02.037_bb0150","doi-asserted-by":"crossref","first-page":"3502","DOI":"10.1016\/j.bmc.2011.04.021","article-title":"Synthesis and characterization of selective dopamine D2 receptor ligands using aripiprazole as the lead compound","volume":"19","author":"Vangveravong","year":"2011","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.jconrel.2020.02.037_bb0155","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/0006-8993(91)90963-V","article-title":"Multiple fluorescent ligands for dopamine receptors. I. Pharmacological characterization and receptor selectivity","volume":"547","author":"Barton","year":"1991","journal-title":"Brain Res."},{"key":"10.1016\/j.jconrel.2020.02.037_bb0160","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1021\/jm0301033","article-title":"Design, synthesis, and evaluation of metabolism-based analogues of haloperidol incapable of forming MPP+-like species","volume":"47","author":"Lyles-Eggleston","year":"2004","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.jconrel.2020.02.037_bb0165","doi-asserted-by":"crossref","first-page":"5739","DOI":"10.1016\/j.bmcl.2004.09.046","article-title":"Haloperidol: towards further understanding of the structural contributions of its pharmacophoric elements at D2-like receptors","volume":"14","author":"Sikazwe","year":"2004","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.jconrel.2020.02.037_bb0170","doi-asserted-by":"crossref","first-page":"1291","DOI":"10.1016\/j.bmc.2011.12.019","article-title":"Multi-receptor drug design: haloperidol as a scaffold for the design and synthesis of atypical antipsychotic agents","volume":"20","author":"Peprah","year":"2012","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.jconrel.2020.02.037_bb0175","series-title":"M.S.B.T.-M.D","first-page":"439","article-title":"Chapter 25 - Murine models of caytaxin deficiency","author":"LeDoux","year":"2015"},{"key":"10.1016\/j.jconrel.2020.02.037_bb0180","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1007\/BF02246184","article-title":"Catalepsy as a rodent model for detecting antipsychotic drugs with extrapyramidal side effect liability","volume":"120","author":"Hoffman","year":"1995","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.jconrel.2020.02.037_bb0185","doi-asserted-by":"crossref","first-page":"1525","DOI":"10.1017\/S1461145711001696","article-title":"Haloperidol conditioned catalepsy in rats: a possible role for D1-like receptors","volume":"15","author":"Banasikowski","year":"2012","journal-title":"Int. J. Neuropsychopharmacol."},{"key":"10.1016\/j.jconrel.2020.02.037_bb0190","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1007\/BF02244876","article-title":"The relationship between motor effects in rats following acute and chronic haloperidol treatment","volume":"116","author":"J\u00f8rgensen","year":"1994","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.jconrel.2020.02.037_bb0195","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1097\/FBP.0000000000000168","article-title":"Antipsychotic drugs on maternal behavior in rats","volume":"26","author":"Li","year":"2015","journal-title":"Behav. Pharmacol."},{"key":"10.1016\/j.jconrel.2020.02.037_bb0200","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/0165-1781(94)90067-1","article-title":"Effect of prolonged treatment with haloperidol on \u201cemotional\u201d defecation and movement in rats in a well-habituated environment","volume":"54","author":"Sachdev","year":"1994","journal-title":"Psychiatry Res."},{"key":"10.1016\/j.jconrel.2020.02.037_bb0205","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.addr.2019.06.008","article-title":"Absorption, distribution, metabolism and excretion of the biomaterials used in Nanocarrier drug delivery systems","volume":"143","author":"Su","year":"2019","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.jconrel.2020.02.037_bb0210","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1177\/070674370004500302","article-title":"Are animal studies of antipsychotics appropriately dosed? Lessons from the bedside to the bench","volume":"45","author":"Kapur","year":"2000","journal-title":"Can. J. Psychiatr."}],"container-title":["Journal of Controlled Release"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168365920301279?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168365920301279?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T17:24:33Z","timestamp":1790184273000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0168365920301279"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,6]]},"references-count":42,"alternative-id":["S0168365920301279"],"URL":"https:\/\/doi.org\/10.1016\/j.jconrel.2020.02.037","relation":{},"ISSN":["0168-3659"],"issn-type":[{"value":"0168-3659","type":"print"}],"subject":[],"published":{"date-parts":[[2020,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Conjugation of haloperidol to PEG allows peripheral localisation of haloperidol and eliminates CNS extrapyramidal effects","name":"articletitle","label":"Article Title"},{"value":"Journal of Controlled Release","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jconrel.2020.02.037","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}